We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Combination of DBT and Standard Mammography Detects Breast Cancer More Often Than Mammography Alone

By MedImaging International staff writers
Posted on 28 Apr 2022

Breast cancer is the most frequent tumor disease worldwide. This is why, women aged 50 and over are offered systematic early detection examinations - so-called mammography screening. Now, a new study on enhanced screening technology involving almost 100,000 women has found that breast cancer can be detected more often by combining digital breast tomosynthesis (DBT) with synthetic 2D mammography than by standard mammographies.

Researchers at the University of Münster (North Rhine-Westphalia, Germany) have been conducting research in the field of innovative imaging technologies and their impact on the efficiency of detecting breast cancer at an early stage. In the ToSyMa study, a combination of DBT and so-called synthetic 2D mammograms was compared with the nowadays screening standard.


Image: Breast cancer can be detected more often than with standard mammographies (Photo courtesy of University of Münster)
Image: Breast cancer can be detected more often than with standard mammographies (Photo courtesy of University of Münster)

Initial results from study phase 1 confirm the assumption that by using the new enhanced mammography technology, breast cancer is detected significantly more often than by using standard mammography. This observation is based on the fact that breast tomosynthesis – an enhanced version of digital mammography – provides technology which, by computing pseudo-3D datasets, reduces any potential overlapping of tissue in the breast, thus promising benefits in making diagnoses. Phase 2 of the ToSyMa study will examine whether the increase in breast cancer diagnoses as a result of screening also leads to improved health in women.

Related Links:
University of Münster 


Mammography System (Analog)
MAM VENUS
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices
Ultrasound Table
Women’s Ultrasound EA Table
Digital X-Ray Detector Panel
Acuity G4

Latest General/Advanced Imaging News

New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents
28 Apr 2022  |   General/Advanced Imaging

AI Algorithm Accurately Predicts Pancreatic Cancer Metastasis Using Routine CT Images
28 Apr 2022  |   General/Advanced Imaging

Cutting-Edge Angio-CT Solution Offers New Therapeutic Possibilities
28 Apr 2022  |   General/Advanced Imaging